patent/KR-100829035-B1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100829035-B1

Outgoing Links

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate	2002-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	KR-100829035-B1
titleOfInvention	Pyrimidine Derivatives for Inhibition of Cell Proliferation
abstract	The present invention relates to compounds of formula (I) and their pharmaceutically acceptable salts and in vivo hydrolyzable esters. The present invention further relates to a method for its manufacture and its use as a medicament, in particular as a medicament for producing a cell cycle inhibitory (anti-cell proliferative) effect in warm blooded animals such as humans.n n n n Formula In n n n n n n n n Wherein the rings A, R 1 , R 3 , R 4 , p, q and n are defined in the specification.
priorityDate	2001-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0114375-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468247473

Total number of triples: 32.